🧾 What This Document Is

This is a proxy statement (Form DEF 14A) for Nu Skin Enterprises. Think of it as an invitation and instruction manual for the company's annual shareholder meeting. It tells you what will be voted on, provides details on the company's leadership and pay, and asks for your vote on key decisions.

👉 The big picture: You, as a shareholder, are being asked to vote to elect directors, approve executive pay, approve a new employee stock plan, and ratify the company's auditor.

🏢 What The Company Does

In simple terms, Nu Skin is a global direct selling company. They develop and sell personal care products and nutritional supplements. Their business model relies on a large network of independent salespeople (like brand ambassadors) who sell products directly to customers.

👉 Why it matters: Their performance is heavily tied to the strength and growth of this sales force and consumer demand for their products, which the proxy notes has faced "macroeconomic pressures."

👥 Meet the Board: Who's Running the Show

The company is asking you to elect nine directors to its board. Here are the key highlights:

Lead Independent Director: Daniel W. Campbell (since 1997)
Executive Chairman: Steven J. Lund (a founder, since 1996)
CEO: Ryan S. Napierski (since 2021)
Newest Director: James M. Winett (joined 2025)
Diversity: The board notes it is 33% diverse (gender and/or race/ethnicity).
Key Skills: The board highlights expertise in finance, international operations, digital sales, and direct selling industry experience.

👉 The takeaway: The board is a mix of long-tenured members with deep company history and newer members with fresh perspectives. Only the CEO and Executive Chairman are not considered "independent."

💰 Executive Compensation: Pay-for-Performance in Action

This section details how top executives are paid, and it tells a story of tough times.

2025 Was a Tough Year: Due to poor financial results (lower revenue and profit than targets), cash bonuses for executives were slashed. CEO Ryan Napierski's cash bonus was just 22% of his target.
Salary Cuts Happened: In early 2025, base salaries for all top executives were reduced as a cost-saving measure.
The Pay Mix: Most executive pay is "at-risk" – meaning it's tied to hitting company goals. For the CEO, 71% of his target pay was in long-term stock awards, aligning his wealth with the stock price.
Stock Performance Matters: A large portion of pay comes in "Performance Restricted Stock Units" (PRSUs) that only vest if the company hits multi-year profit goals. The proxy shows mixed results from past awards, with some earning zero shares.

👉 Why it matters: This demonstrates a "pay-for-performance" philosophy. When the company misses targets, executive pay is directly and significantly impacted.

🔄 Key Executive Changes: A CFO Transition

The proxy discloses a major leadership change:

CFO Resigned: James D. Thomas resigned as CFO on March 17, 2026.
Interim CFO Appointed: Chelsea K. Lantz, the VP and Corporate Controller, was named Interim CFO while a permanent replacement is sought. She has been with the company since 2011.
Expanded COO Role: Chayce D. Clark, already the Chief Legal Officer, also took on the role of Chief Operating Officer in March 2026.

📦 Corporate Governance & Policies

The company highlights its governance "best practices":

Separate Chair & CEO: The roles are split (Lund is Chair, Napierski is CEO), with a Lead Independent Director.
Annual Director Elections: No "staggered" board; all directors face re-election every year.
Robust Policies: They have policies prohibiting executives and directors from hedging or pledging company stock.
Clawback Policy: They can recoup incentive pay if financial results are later restated.

📊 The Proposals You're Voting On

Here’s what you’re being asked to approve:

ELECT DIRECTORS: Vote to approve the nine-nominee slate.
ADVISORY VOTE ON EXECUTIVE PAY: A non-binding "say-on-pay" vote. Last year, 97% of votes were in favor.
APPROVE NEW INCENTIVE PLAN: Vote to approve the Amended and Restated 2024 Omnibus Incentive Plan. This is the pool for granting stock awards to employees.
RATIFY AUDITOR: Vote to confirm PricewaterhouseCoopers LLP as the independent accounting firm for 2026.

🔮 What's Next & Strategic Focus

While the document is about governance, it hints at the company's current challenges and focus:

Navigating Headwinds: The company acknowledges facing "macroeconomic pressures" impacting customer spending.
Transformation in Progress: They mention "headwinds from the transformation process," indicating they are undergoing a significant strategic shift.
2026 Goals: New executive strategic goals for 2026 focus on improving gross margin, expanding in India, and launching the "Prysm iO intelligent wellness platform."

⚖️ Big Picture: Strengths & Risks

👍 Strengths: Clear pay-for-performance alignment, established global brand, governance policies that favor shareholder interests.
⚠️ Risks: Heavy reliance on a direct sales force which can be volatile, recent financial underperformance impacting pay, undergoing a potentially disruptive transformation, and the key transition in the CFO role.

🧠 The Analogy

Running Nu Skin right now is like captaining a large ship (the established company) through a storm (economic headwinds) while trying to retrofit it for a new voyage (business transformation). The captain (CEO) and crew (executives) are seeing their bonuses cut because the ship is off schedule, and the navigator (CFO) has just left the bridge. The shareholders (you) are being asked to confirm the officers (board) steering the ship have the right tools (new incentive plan) to get through the storm.

📇 Key Contacts & People

Chairman of the Board: Steven J. Lund
President & CEO: Ryan S. Napierski
Lead Independent Director: Daniel W. Campbell
Interim CFO: Chelsea K. Lantz
Chief Operating Officer & Chief Legal Officer: Chayce D. Clark
Corporate Secretary: (Not named in provided text, but communications can be sent to them at the company address)
Independent Inspector of Election: Alliance Advisors, LLC
Company Address: 75 West Center Street, Provo, Utah 84601

🧩 Final Takeaway

This proxy reveals a company facing financial headwinds, resulting in significant cuts to executive pay. Shareholders are being asked to endorse the leadership team and their new incentive plan as they navigate a business transformation, all while the board maintains a governance structure designed to hold management accountable.

NU SKIN ENTERPRISES, INC. — DEF 14A Filing